Reuters logo
BRIEF-Roche says OCREVUS approved in Switzerland for forms of multiple sclerosis
September 28, 2017 / 5:02 AM / in 23 days

BRIEF-Roche says OCREVUS approved in Switzerland for forms of multiple sclerosis

Sept 28 (Reuters) - Roche Holding Ag

* OCREVUS (ocrelizumab) approved in Switzerland for primary progressive and relapsing forms of multiple sclerosis Source text for Eikon: [here ] Further company coverage: (Reporting by Zurich Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below